17 research outputs found
IBUPROFEN AS A MEDICATION FOR A CORRECTION OF SYMPTOMS OF NORMAL VACCINAL PROCESS IN CHILDREN
The pathogenetic approach to treatment of symptoms of normal vaccinal process in children after standard vaccination, based on the results of application of anti9inflammatory medications βΒ ibuprofen (nurofen for children) and paracetamol is presented in this article. Clinical activity of ibuprofen was established on the basis of clinica catamnestic observation of 856 vaccinated children aged from 3 months to 3 years. recommendations for application of these medications as a treatment for a correction of vaccinal reactions are given.Key words: children, ibuprofen, paracetamol, vaccination
ΠΠ»ΠΈΠ½ΠΈΠΊΠΎ-Π°Π½Π°ΠΌΠ½Π΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΊΡΠΈΡΠ΅ΡΠΈΠΈ ΡΠ°Π½Π½Π΅ΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΊΠ·Π΅ΠΌΡ Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌ Π΄Π΅ΡΠΌΠ°ΡΠΈΡΠΎΠΌ
Rationale: Herpetic eczema (HE), being one of manifestations of generalized Herpes simplex virus (HSV) infection, presents mostly as aΒ complication of atopic dermatitis (AD). This is aΒ potentially life-threatening infection with mortality rates of up to 9%. Early diagnosis and timely beginning of antiviral treatment may help to avoid severe complications and mortality in children with HE.Aim: To evaluate factors predisposing to the development of HE in children with AD and to identify aΒ high risk group.Materials and methods: One hundred and fifty (150) children with AD aged from 4Β months to 18Β years were recruited into this one-center prospective stratified observational study. The main group included 113Β children with HE with underlying AD, while the comparison group comprised 37Β children with AD exacerbations without HE. HSV infection was confirmed by determination of the viral DNA in blood by polymerase chain reaction. The severity of AD at study entry and during follow up was assessed with SCORAD scale.Results: All children with HE + AD (100%) had been in contact with individuals with clinical manifestations of HSV infection (35.1%Β in the comparison group, p < 0.001). The main predictors of HE in AD patients were as follows: age below 1Β year (relative risk increase (RRI) 2.86, 95%Β confidence interval (CI) -7.91 / -0.68, p < 0.001), autumn and winter season (RRI 1.68, 95%Β CIΒ -5.3 / -0.15, p = 0.018), moderate and severe AD (RRI 0.91, 95%Β CI -2.11 / -0.17, p < 0.002).Conclusion: A combination of 3 risk factors, such as age below 1Β year, autumn and winter season, moderate and severe AD, puts aΒ patient into aΒ high risk of HE. Children from the risk group should be isolated from patients with manifest HSV infection.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. ΠΠ΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠΊΠ·Π΅ΠΌΠ° (ΠΠ), Π±ΡΠ΄ΡΡΠΈ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠ΅ΠΌ Π³Π΅Π½Π΅ΡΠ°Π»ΠΈΠ·ΠΎΠ²Π°Π½Π½ΠΎΠΉ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ, Π²ΡΠ·Π²Π°Π½Π½ΠΎΠΉ Π²ΠΈΡΡΡΠΎΠΌ ΠΏΡΠΎΡΡΠΎΠ³ΠΎ Π³Π΅ΡΠΏΠ΅ΡΠ° (ΠΠΠ), Π³Π»Π°Π²Π½ΡΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, ΠΎΡΠ»ΠΎΠΆΠ½ΡΠ΅Ρ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π΄Π΅ΡΠΌΠ°ΡΠΈΡΠ° (ΠΡΠ). ΠΡΠΎ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ ΠΎΠΏΠ°ΡΠ½Π°Ρ Π΄Π»Ρ ΠΆΠΈΠ·Π½ΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ, ΡΠΌΠ΅ΡΡΠ½ΠΎΡΡΡ ΠΎΡ ΠΊΠΎΡΠΎΡΠΎΠΉ Π΄ΠΎΡΡΠΈΠ³Π°Π΅Ρ 9%. Π Π°Π½Π½ΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΈΒ ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎ Π½Π°ΡΠ°ΡΠΎΠ΅ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΠΈΠ·Π±Π΅ΠΆΠ°ΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΡΠΆΠ΅Π»ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΠΈΒ ΡΠΌΠ΅ΡΡΠ΅Π»ΡΠ½ΡΡ
ΠΈΡΡ
ΠΎΠ΄ΠΎΠ² ΡΡΠ΅Π΄ΠΈ Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΠ.Π¦Π΅Π»ΡΒ β ΠΏΡΠΎΠ²Π΅ΡΡΠΈ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»Π°Π³Π°ΡΡΠΈΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΠ ΡΒ Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΡΠ ΠΈΒ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈΡΡ Π³ΡΡΠΏΠΏΡ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ°.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈΒ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΒ ΠΎΠ΄Π½ΠΎΡΠ΅Π½ΡΡΠΎΠ²ΠΎΠ΅ ΠΏΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ ΡΡΡΠ°ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ΅ ΠΎΠ±ΡΠ΅ΡΠ²Π°ΡΠΈΠΎΠ½Π½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΊΠ»ΡΡΠ΅Π½Ρ 150Β Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΡΠ Π²Β Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 4Β ΠΌΠ΅ΡΡΡΠ΅Π² Π΄ΠΎ 18Β Π»Π΅Ρ. ΠΡΠ½ΠΎΠ²Π½ΡΡ Π³ΡΡΠΏΠΏΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 113Β Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΠ, ΡΠ°Π·Π²ΠΈΠ²ΡΠ΅ΠΉΡΡ Π½Π° ΡΠΎΠ½Π΅ ΠΡΠ, Π³ΡΡΠΏΠΏΡ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡΒ β 37Β Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΡΠ Π²Β ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΡ, Π½Π΅ ΡΠΎΡΠ΅ΡΠ°Π²ΡΠΈΠΌΡΡ ΡΒ ΠΠ. ΠΠΠ-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½Π° ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ΠΌ ΠΠΠ Π²ΠΈΡΡΡΠ° Π²Β ΠΊΡΠΎΠ²ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠ°Π·Π½ΠΎΠΉ ΡΠ΅ΠΏΠ½ΠΎΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ. Π‘ΡΠ΅ΠΏΠ΅Π½Ρ ΡΡΠΆΠ΅ΡΡΠΈ ΠΡΠ Π½Π° ΠΌΠΎΠΌΠ΅Π½Ρ ΠΎΡΠΌΠΎΡΡΠ° ΠΈΒ Π²Β Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ΅ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΏΠΎ ΡΠΊΠ°Π»Π΅ SCORAD.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠ΅ Π΄Π΅ΡΠΈ ΡΒ ΠΠ ΠΏΡΠΈ ΠΡΠ (100%) ΠΊΠΎΠ½ΡΠ°ΠΊΡΠΈΡΠΎΠ²Π°Π»ΠΈ ΡΒ Π»ΡΠ΄ΡΠΌΠΈ, ΠΈΠΌΠ΅ΡΡΠΈΠΌΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΠΠΠ-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ (35,1%Β Π²Β Π³ΡΡΠΏΠΏΠ΅ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ, p < 0,001). ΠΡΠ½ΠΎΠ²Π½ΡΠΌΠΈ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΎΡΠ°ΠΌΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΠ ΡΒ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΒ ΠΡΠ ΡΠ²Π»ΡΡΡΡΡ: Π²ΠΎΠ·ΡΠ°ΡΡ Π΄ΠΎ 1Β Π³ΠΎΠ΄Π° (ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ° (ΠΠΠ ) 2,86, 95%Β Π΄ΠΎΠ²Π΅ΡΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΠΈΠ½ΡΠ΅ΡΠ²Π°Π» (ΠΠ) -7,91 / -0,68, p < 0,001), ΠΎΡΠ΅Π½Π½Π΅-Π·ΠΈΠΌΠ½ΠΈΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ Π³ΠΎΠ΄Π° (ΠΠΠ 1,68, 95%Β ΠΠ -5,3 / -0,15, p = 0,018), ΡΡΠ΅Π΄Π½Π΅ΡΡΠΆΠ΅Π»Π°Ρ ΠΈΠ»ΠΈ ΡΡΠΆΠ΅Π»Π°Ρ ΡΠΎΡΠΌΠ° ΠΡΠ (ΠΠΠ 0,91, 95%Β ΠΠ -2,11 / -0,17, p < 0,002).ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π‘ΠΎΡΠ΅ΡΠ°Π½ΠΈΠ΅ ΡΠ°ΠΊΠΈΡ
Β ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΈΡΠΊΠ°, ΠΊΠ°ΠΊ Π²ΠΎΠ·ΡΠ°ΡΡ Π΄ΠΎ 1Β Π³ΠΎΠ΄Π°, ΠΎΡΠ΅Π½Π½Π΅-Π·ΠΈΠΌΠ½ΠΈΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ Π³ΠΎΠ΄Π°, ΡΡΠ΅Π΄Π½Π΅ΡΡΠΆΠ΅Π»Π°Ρ ΠΈΒ ΡΡΠΆΠ΅Π»Π°Ρ ΡΠΎΡΠΌΡ ΠΡΠ, ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΎΡΠ½Π΅ΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° ΠΊΒ Π³ΡΡΠΏΠΏΠ΅ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ° ΠΏΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΠ. ΠΠ΅ΡΡΠΌ ΠΈΠ· Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ ΡΠ°Π·ΠΎΠ±ΡΠ΅Π½ΠΈΠ΅ ΡΒ Π±ΠΎΠ»ΡΠ½ΡΠΌΠΈ ΠΌΠ°Π½ΠΈΡΠ΅ΡΡΠ½ΠΎΠΉ ΠΠΠ-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ
UP TO DATE APPROACHES TO IMPROVING IMMUNOBIOLOGICAL THERAPY OF VIRAL DIARRHEA OF CHILDREN
The article considers issues of therapeutic tactics for virus infections of children. The authors explain the essence of changes, which take place in the immune system of body under this pathology. The article describes immuno pathogenesis of acute enteric infections and the effect of lactoprobiotics on immuno-competent cells. The findings prove the advisability of applying this group of medications for a complex therapy of children with acute diarrhea disturbance.Key words: acute enteric infections, immuno-pathogenesis, treatment, lacto probiotics, children
UP TO DATE APPROACHES TO IMPROVING IMMUNOBIOLOGICAL THERAPY OF VIRAL DIARRHEA OF CHILDREN
The article considers issues of therapeutic tactics for virus infections of children. The authors explain the essence of changes, which take place in the immune system of body under this pathology. The article describes immuno pathogenesis of acute enteric infections and the effect of lactoprobiotics on immuno-competent cells. The findings prove the advisability of applying this group of medications for a complex therapy of children with acute diarrhea disturbance.Key words: acute enteric infections, immuno-pathogenesis, treatment, lacto probiotics, children
ΠΠ»ΠΈΠ½ΠΈΠΊΠΎ-Π°Π½Π°ΠΌΠ½Π΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΊΡΠΈΡΠ΅ΡΠΈΠΈ ΡΠ°Π½Π½Π΅ΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΊΠ·Π΅ΠΌΡ Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌ Π΄Π΅ΡΠΌΠ°ΡΠΈΡΠΎΠΌ
Rationale: Herpetic eczema (HE), being one of manifestations of generalized Herpes simplex virus (HSV) infection, presents mostly as aΒ complication of atopic dermatitis (AD). This is aΒ potentially life-threatening infection with mortality rates of up to 9%. Early diagnosis and timely beginning of antiviral treatment may help to avoid severe complications and mortality in children with HE.Aim: To evaluate factors predisposing to the development of HE in children with AD and to identify aΒ high risk group.Materials and methods: One hundred and fifty (150) children with AD aged from 4Β months to 18Β years were recruited into this one-center prospective stratified observational study. The main group included 113Β children with HE with underlying AD, while the comparison group comprised 37Β children with AD exacerbations without HE. HSV infection was confirmed by determination of the viral DNA in blood by polymerase chain reaction. The severity of AD at study entry and during follow up was assessed with SCORAD scale.Results: All children with HE + AD (100%) had been in contact with individuals with clinical manifestations of HSV infection (35.1%Β in the comparison group, p 0.001). The main predictors of HE in AD patients were as follows: age below 1Β year (relative risk increase (RRI) 2.86, 95%Β confidence interval (CI) -7.91 / -0.68, p 0.001), autumn and winter season (RRI 1.68, 95%Β CIΒ -5.3 / -0.15, p = 0.018), moderate and severe AD (RRI 0.91, 95%Β CI -2.11 / -0.17, p 0.002).Conclusion: A combination of 3 risk factors, such as age below 1Β year, autumn and winter season, moderate and severe AD, puts aΒ patient into aΒ high risk of HE. Children from the risk group should be isolated from patients with manifest HSV infection.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. ΠΠ΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠΊΠ·Π΅ΠΌΠ° (ΠΠ), Π±ΡΠ΄ΡΡΠΈ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠ΅ΠΌ Π³Π΅Π½Π΅ΡΠ°Π»ΠΈΠ·ΠΎΠ²Π°Π½Π½ΠΎΠΉ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ, Π²ΡΠ·Π²Π°Π½Π½ΠΎΠΉ Π²ΠΈΡΡΡΠΎΠΌ ΠΏΡΠΎΡΡΠΎΠ³ΠΎ Π³Π΅ΡΠΏΠ΅ΡΠ° (ΠΠΠ), Π³Π»Π°Π²Π½ΡΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, ΠΎΡΠ»ΠΎΠΆΠ½ΡΠ΅Ρ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π΄Π΅ΡΠΌΠ°ΡΠΈΡΠ° (ΠΡΠ). ΠΡΠΎ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ ΠΎΠΏΠ°ΡΠ½Π°Ρ Π΄Π»Ρ ΠΆΠΈΠ·Π½ΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ, ΡΠΌΠ΅ΡΡΠ½ΠΎΡΡΡ ΠΎΡ ΠΊΠΎΡΠΎΡΠΎΠΉ Π΄ΠΎΡΡΠΈΠ³Π°Π΅Ρ 9%. Π Π°Π½Π½ΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΈΒ ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎ Π½Π°ΡΠ°ΡΠΎΠ΅ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΠΈΠ·Π±Π΅ΠΆΠ°ΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΡΠΆΠ΅Π»ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΠΈΒ ΡΠΌΠ΅ΡΡΠ΅Π»ΡΠ½ΡΡ
ΠΈΡΡ
ΠΎΠ΄ΠΎΠ² ΡΡΠ΅Π΄ΠΈ Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΠ.Π¦Π΅Π»ΡΒ β ΠΏΡΠΎΠ²Π΅ΡΡΠΈ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»Π°Π³Π°ΡΡΠΈΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΠ ΡΒ Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΡΠ ΠΈΒ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈΡΡ Π³ΡΡΠΏΠΏΡ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ°.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈΒ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΒ ΠΎΠ΄Π½ΠΎΡΠ΅Π½ΡΡΠΎΠ²ΠΎΠ΅ ΠΏΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ ΡΡΡΠ°ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ΅ ΠΎΠ±ΡΠ΅ΡΠ²Π°ΡΠΈΠΎΠ½Π½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΊΠ»ΡΡΠ΅Π½Ρ 150Β Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΡΠ Π²Β Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 4Β ΠΌΠ΅ΡΡΡΠ΅Π² Π΄ΠΎ 18Β Π»Π΅Ρ. ΠΡΠ½ΠΎΠ²Π½ΡΡ Π³ΡΡΠΏΠΏΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 113Β Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΠ, ΡΠ°Π·Π²ΠΈΠ²ΡΠ΅ΠΉΡΡ Π½Π° ΡΠΎΠ½Π΅ ΠΡΠ, Π³ΡΡΠΏΠΏΡ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡΒ β 37Β Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΡΠ Π²Β ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΡ, Π½Π΅ ΡΠΎΡΠ΅ΡΠ°Π²ΡΠΈΠΌΡΡ ΡΒ ΠΠ. ΠΠΠ-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½Π° ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ΠΌ ΠΠΠ Π²ΠΈΡΡΡΠ° Π²Β ΠΊΡΠΎΠ²ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠ°Π·Π½ΠΎΠΉ ΡΠ΅ΠΏΠ½ΠΎΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ. Π‘ΡΠ΅ΠΏΠ΅Π½Ρ ΡΡΠΆΠ΅ΡΡΠΈ ΠΡΠ Π½Π° ΠΌΠΎΠΌΠ΅Π½Ρ ΠΎΡΠΌΠΎΡΡΠ° ΠΈΒ Π²Β Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ΅ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΏΠΎ ΡΠΊΠ°Π»Π΅ SCORAD.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠ΅ Π΄Π΅ΡΠΈ ΡΒ ΠΠ ΠΏΡΠΈ ΠΡΠ (100%) ΠΊΠΎΠ½ΡΠ°ΠΊΡΠΈΡΠΎΠ²Π°Π»ΠΈ ΡΒ Π»ΡΠ΄ΡΠΌΠΈ, ΠΈΠΌΠ΅ΡΡΠΈΠΌΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΠΠΠ-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ (35,1%Β Π²Β Π³ΡΡΠΏΠΏΠ΅ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ, p 0,001). ΠΡΠ½ΠΎΠ²Π½ΡΠΌΠΈ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΎΡΠ°ΠΌΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΠ ΡΒ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΒ ΠΡΠ ΡΠ²Π»ΡΡΡΡΡ: Π²ΠΎΠ·ΡΠ°ΡΡ Π΄ΠΎ 1Β Π³ΠΎΠ΄Π° (ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ° (ΠΠΠ ) 2,86, 95%Β Π΄ΠΎΠ²Π΅ΡΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΠΈΠ½ΡΠ΅ΡΠ²Π°Π» (ΠΠ) -7,91 / -0,68, p 0,001), ΠΎΡΠ΅Π½Π½Π΅-Π·ΠΈΠΌΠ½ΠΈΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ Π³ΠΎΠ΄Π° (ΠΠΠ 1,68, 95%Β ΠΠ -5,3 / -0,15, p = 0,018), ΡΡΠ΅Π΄Π½Π΅ΡΡΠΆΠ΅Π»Π°Ρ ΠΈΠ»ΠΈ ΡΡΠΆΠ΅Π»Π°Ρ ΡΠΎΡΠΌΠ° ΠΡΠ (ΠΠΠ 0,91, 95%Β ΠΠ -2,11 / -0,17, p 0,002).ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π‘ΠΎΡΠ΅ΡΠ°Π½ΠΈΠ΅ ΡΠ°ΠΊΠΈΡ
Β ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΈΡΠΊΠ°, ΠΊΠ°ΠΊ Π²ΠΎΠ·ΡΠ°ΡΡ Π΄ΠΎ 1Β Π³ΠΎΠ΄Π°, ΠΎΡΠ΅Π½Π½Π΅-Π·ΠΈΠΌΠ½ΠΈΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ Π³ΠΎΠ΄Π°, ΡΡΠ΅Π΄Π½Π΅ΡΡΠΆΠ΅Π»Π°Ρ ΠΈΒ ΡΡΠΆΠ΅Π»Π°Ρ ΡΠΎΡΠΌΡ ΠΡΠ, ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΎΡΠ½Π΅ΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° ΠΊΒ Π³ΡΡΠΏΠΏΠ΅ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ° ΠΏΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΠ. ΠΠ΅ΡΡΠΌ ΠΈΠ· Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ ΡΠ°Π·ΠΎΠ±ΡΠ΅Π½ΠΈΠ΅ ΡΒ Π±ΠΎΠ»ΡΠ½ΡΠΌΠΈ ΠΌΠ°Π½ΠΈΡΠ΅ΡΡΠ½ΠΎΠΉ ΠΠΠ-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ
ΠΠ»ΠΈΠ½ΠΈΠΊΠΎ-Π°Π½Π°ΠΌΠ½Π΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΊΡΠΈΡΠ΅ΡΠΈΠΈ ΡΠ°Π½Π½Π΅ΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΊΠ·Π΅ΠΌΡ Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌ Π΄Π΅ΡΠΌΠ°ΡΠΈΡΠΎΠΌ
Rationale: Herpetic eczema (HE), being one of manifestations of generalized Herpes simplex virus (HSV) infection, presents mostly as aΒ complication of atopic dermatitis (AD). This is aΒ potentially life-threatening infection with mortality rates of up to 9%. Early diagnosis and timely beginning of antiviral treatment may help to avoid severe complications and mortality in children with HE.Aim: To evaluate factors predisposing to the development of HE in children with AD and to identify aΒ high risk group.Materials and methods: One hundred and fifty (150) children with AD aged from 4Β months to 18Β years were recruited into this one-center prospective stratified observational study. The main group included 113Β children with HE with underlying AD, while the comparison group comprised 37Β children with AD exacerbations without HE. HSV infection was confirmed by determination of the viral DNA in blood by polymerase chain reaction. The severity of AD at study entry and during follow up was assessed with SCORAD scale.Results: All children with HE + AD (100%) had been in contact with individuals with clinical manifestations of HSV infection (35.1%Β in the comparison group, p < 0.001). The main predictors of HE in AD patients were as follows: age below 1Β year (relative risk increase (RRI) 2.86, 95%Β confidence interval (CI) -7.91 / -0.68, p < 0.001), autumn and winter season (RRI 1.68, 95%Β CIΒ -5.3 / -0.15, p = 0.018), moderate and severe AD (RRI 0.91, 95%Β CI -2.11 / -0.17, p < 0.002).Conclusion: A combination of 3 risk factors, such as age below 1Β year, autumn and winter season, moderate and severe AD, puts aΒ patient into aΒ high risk of HE. Children from the risk group should be isolated from patients with manifest HSV infection.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. ΠΠ΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠΊΠ·Π΅ΠΌΠ° (ΠΠ), Π±ΡΠ΄ΡΡΠΈ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠ΅ΠΌ Π³Π΅Π½Π΅ΡΠ°Π»ΠΈΠ·ΠΎΠ²Π°Π½Π½ΠΎΠΉ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ, Π²ΡΠ·Π²Π°Π½Π½ΠΎΠΉ Π²ΠΈΡΡΡΠΎΠΌ ΠΏΡΠΎΡΡΠΎΠ³ΠΎ Π³Π΅ΡΠΏΠ΅ΡΠ° (ΠΠΠ), Π³Π»Π°Π²Π½ΡΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, ΠΎΡΠ»ΠΎΠΆΠ½ΡΠ΅Ρ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π΄Π΅ΡΠΌΠ°ΡΠΈΡΠ° (ΠΡΠ). ΠΡΠΎ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ ΠΎΠΏΠ°ΡΠ½Π°Ρ Π΄Π»Ρ ΠΆΠΈΠ·Π½ΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ, ΡΠΌΠ΅ΡΡΠ½ΠΎΡΡΡ ΠΎΡ ΠΊΠΎΡΠΎΡΠΎΠΉ Π΄ΠΎΡΡΠΈΠ³Π°Π΅Ρ 9%. Π Π°Π½Π½ΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΈΒ ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎ Π½Π°ΡΠ°ΡΠΎΠ΅ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΠΈΠ·Π±Π΅ΠΆΠ°ΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΡΠΆΠ΅Π»ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΠΈΒ ΡΠΌΠ΅ΡΡΠ΅Π»ΡΠ½ΡΡ
ΠΈΡΡ
ΠΎΠ΄ΠΎΠ² ΡΡΠ΅Π΄ΠΈ Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΠ.Π¦Π΅Π»ΡΒ β ΠΏΡΠΎΠ²Π΅ΡΡΠΈ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»Π°Π³Π°ΡΡΠΈΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΠ ΡΒ Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΡΠ ΠΈΒ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈΡΡ Π³ΡΡΠΏΠΏΡ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ°.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈΒ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΒ ΠΎΠ΄Π½ΠΎΡΠ΅Π½ΡΡΠΎΠ²ΠΎΠ΅ ΠΏΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ ΡΡΡΠ°ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ΅ ΠΎΠ±ΡΠ΅ΡΠ²Π°ΡΠΈΠΎΠ½Π½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΊΠ»ΡΡΠ΅Π½Ρ 150Β Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΡΠ Π²Β Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 4Β ΠΌΠ΅ΡΡΡΠ΅Π² Π΄ΠΎ 18Β Π»Π΅Ρ. ΠΡΠ½ΠΎΠ²Π½ΡΡ Π³ΡΡΠΏΠΏΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 113Β Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΠ, ΡΠ°Π·Π²ΠΈΠ²ΡΠ΅ΠΉΡΡ Π½Π° ΡΠΎΠ½Π΅ ΠΡΠ, Π³ΡΡΠΏΠΏΡ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡΒ β 37Β Π΄Π΅ΡΠ΅ΠΉ ΡΒ ΠΡΠ Π²Β ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΡ, Π½Π΅ ΡΠΎΡΠ΅ΡΠ°Π²ΡΠΈΠΌΡΡ ΡΒ ΠΠ. ΠΠΠ-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½Π° ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ΠΌ ΠΠΠ Π²ΠΈΡΡΡΠ° Π²Β ΠΊΡΠΎΠ²ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠ°Π·Π½ΠΎΠΉ ΡΠ΅ΠΏΠ½ΠΎΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ. Π‘ΡΠ΅ΠΏΠ΅Π½Ρ ΡΡΠΆΠ΅ΡΡΠΈ ΠΡΠ Π½Π° ΠΌΠΎΠΌΠ΅Π½Ρ ΠΎΡΠΌΠΎΡΡΠ° ΠΈΒ Π²Β Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ΅ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΏΠΎ ΡΠΊΠ°Π»Π΅ SCORAD.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠ΅ Π΄Π΅ΡΠΈ ΡΒ ΠΠ ΠΏΡΠΈ ΠΡΠ (100%) ΠΊΠΎΠ½ΡΠ°ΠΊΡΠΈΡΠΎΠ²Π°Π»ΠΈ ΡΒ Π»ΡΠ΄ΡΠΌΠΈ, ΠΈΠΌΠ΅ΡΡΠΈΠΌΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΠΠΠ-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ (35,1%Β Π²Β Π³ΡΡΠΏΠΏΠ΅ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ, p < 0,001). ΠΡΠ½ΠΎΠ²Π½ΡΠΌΠΈ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΎΡΠ°ΠΌΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΠ ΡΒ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΒ ΠΡΠ ΡΠ²Π»ΡΡΡΡΡ: Π²ΠΎΠ·ΡΠ°ΡΡ Π΄ΠΎ 1Β Π³ΠΎΠ΄Π° (ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ° (ΠΠΠ ) 2,86, 95%Β Π΄ΠΎΠ²Π΅ΡΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΠΈΠ½ΡΠ΅ΡΠ²Π°Π» (ΠΠ) -7,91 / -0,68, p < 0,001), ΠΎΡΠ΅Π½Π½Π΅-Π·ΠΈΠΌΠ½ΠΈΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ Π³ΠΎΠ΄Π° (ΠΠΠ 1,68, 95%Β ΠΠ -5,3 / -0,15, p = 0,018), ΡΡΠ΅Π΄Π½Π΅ΡΡΠΆΠ΅Π»Π°Ρ ΠΈΠ»ΠΈ ΡΡΠΆΠ΅Π»Π°Ρ ΡΠΎΡΠΌΠ° ΠΡΠ (ΠΠΠ 0,91, 95%Β ΠΠ -2,11 / -0,17, p < 0,002).ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π‘ΠΎΡΠ΅ΡΠ°Π½ΠΈΠ΅ ΡΠ°ΠΊΠΈΡ
Β ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΈΡΠΊΠ°, ΠΊΠ°ΠΊ Π²ΠΎΠ·ΡΠ°ΡΡ Π΄ΠΎ 1Β Π³ΠΎΠ΄Π°, ΠΎΡΠ΅Π½Π½Π΅-Π·ΠΈΠΌΠ½ΠΈΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ Π³ΠΎΠ΄Π°, ΡΡΠ΅Π΄Π½Π΅ΡΡΠΆΠ΅Π»Π°Ρ ΠΈΒ ΡΡΠΆΠ΅Π»Π°Ρ ΡΠΎΡΠΌΡ ΠΡΠ, ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΎΡΠ½Π΅ΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° ΠΊΒ Π³ΡΡΠΏΠΏΠ΅ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ° ΠΏΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΠ. ΠΠ΅ΡΡΠΌ ΠΈΠ· Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ ΡΠ°Π·ΠΎΠ±ΡΠ΅Π½ΠΈΠ΅ ΡΒ Π±ΠΎΠ»ΡΠ½ΡΠΌΠΈ ΠΌΠ°Π½ΠΈΡΠ΅ΡΡΠ½ΠΎΠΉ ΠΠΠ-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ
Tissue-resident natural killer cells: Features of functioning in the uterus and decidual membrane [Π’ΠΊΠ°Π½Π΅ΡΠ΅Π·ΠΈΠ΄Π΅Π½ΡΠ½ΡΠ΅ Π½Π°ΡΡΡΠ°Π»ΡΠ½ΡΠ΅ ΠΊΠΈΠ»Π»Π΅ΡΡ: ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π² ΠΌΠ°ΡΠΊΠ΅ ΠΈ Π΄Π΅ΡΠΈΠ΄ΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΎΠ±ΠΎΠ»ΠΎΡΠΊΠ΅]
Natural killers are a heterogeneous population of innate immune lymphocytes, among which in recent years 2 categories of cells have been distinguished - circulating (cNK) and tissue-resident (trNK). The circulating pool of these cells is now fairly well characterized: these are cells of bone marrow origin with predominantly cytolytic activity, predominanly CD56dimCD16+ phenotype and a high level of perforin and granzymes expression. The tissue-resident pool has not yet been sufficiently studied, but a number of its features have been established: the ability to differentiate in tissues, the predominance of the CD56brightCD16- phenotype, the ability to produce high levels of certain regulatory cytokines (IFN-Ξ³, TNFΞ±, GM-CSF), the nature of the expression of receptors specific to class I histocompatibility molecules, etc. One of the most important features of trNKs is that their properties correspond to the specific organ where they are localized. This review is devoted to the characteristics of the natural killer cells of the uterus (uNK) and the decidual membrane (dNK) during pregnancy, the features of their origin, phenotype, cytokine production and the set of implemented functions. Β© 2021 Meditsina Publishers. All rights reserved
OPPORTUNITIES TO USE THE LACTOCONTAINING PROBIOTICS IN CHILDREN PRACTICES
The article characterizes the modern approach to the lacto containing probiotics application in the clinical practices. The authors clarify the mechanisms of the functional activity of the lacto bacteria, l. reuteri inclusive. It is recommended to use the lacto containing probiotics in the complex therapy for acute enteric infections, gastroenterological and allergic diseases, functional disorders of the gastrointestinal tract, secondary immunodeficiency states.Key words: probiotics, lacto bacteria, children, infectious and noninfectious diseases of the gastrointestinal tract, nutrition, immunity
Herpetic eczema in children with atopic dermatitis: Prognosis, clinical and immunological diagnostics and management tactics
Herpetic eczema (HE), being a manifestation of disseminated herpetic infection, mainly complicates the course of atopic dermatitis (AtD). This is a potentially life-threatening infection for children, the mortality of which, according to the literature, reaches 9%. Early diagnosis of HE helps to reduce the incidence of adverse outcomes and improve treatment quality for these patients. The goal is to improve the management tactics of children with herpetic eczema based on the patient-oriented algorithm for monitoring children with AtD risk groups, taking into account the predictors complex of disease development and severity. Material and methods: the single-center prospective observational study included 150 children aged from 4 months to 18 years with AtD. The main group consisted of 113 children with HE caused by AtD, the comparison group β 37 children with AtD in the exacerbation period not combined with HE. HSV infection is confirmed by determining the virus DNA in blood by the method of polymerase chain reaction. The diagnosis of AtD in children was verified according to the criteria proposed by J. Hanifin and G. Rajka. The severity of AtD at the time of inspection was assessed according to the SCORAD scale. Results: the main predictors of HE development in patients with AtD are: age up to 1 year (increase in relative risk (IRR) 2,86, 95% confidence interval (CI) 7,91/0,68, p<0,001), autumn-winter period (IRR 1,68, 95% CI 5,3/0,15, p=0,018), close relatives with combination of pollinosis and asthma (IRR 2,56, 95% CI β 9,95/β0,16, p<0,001), moderate or severe form of AtD (IRR 0,91, 95% CI β 2,11/β0,17, p<0,001). Laboratory immunological signs of HE developing risk in children with AtD include eosinophilia more than 3β’109/l (p<0,001); an increased level of IL8 more than 2 times the norm value (p<0,001); prediction of a severe course of the disease β an increase in total IgE level to 850 kE/l (p<0,017) and an increase TNFΞ± serum concentration above 2 pg/ml (p<0,001). Conclusion: the combination of at least 3 risk factors allows to classify a patient with AtD as a high risk group for HE development with recommendations for nonspecific prophylaxis, namely: separation from patients with manifest HSV infection. If a child has a high risk of HE adverse course, differentiated therapy is necessary, Ρonsidering the possible accession of a secondary infection and the exacerbation of AtD after HE regression. Β© 2019, Pediatria Ltd.. All rights reserved